Jul 22 | Nature News & Comment | Gene-editing technique to treat lung cancer is due to be tested in people in August. Sichuan University's West China Hospital in Chengdu plans to inject lung cancer patients with cells modified using the CRISPR-Cas9 gene-editing technique. The clinical trial received ethical approval from the hospital July 6.
Jul 20 | Bio-IT World | Bioz, Inc. came out of stealth today with the introduction of a search engine for life science experimentation. The company, started by Stanford research scientist Karin Lachmi and serial entrepreneur Daniel Levitt, also announced $3 million in seed funding, led by 5AM Ventures.
Jul 20 | Bio-IT World It's been a busy two years for Seven Bridges. In May 2014, Seven Bridges was introducing its open source cancer informatics pipeline: open source algorithms running on the proprietary Seven Bridges cloud infrastructure. Less than six months later, the company was awarded one of three National Cancer Institute Cloud Pilot contracts.
Jul 18 | Bio-IT World | The Systems Toxicology Computational Challenge results have been announced from the fourth challenge launched by sbv IMPROVER, an international scientific crowdsourcing initiative.
Jul 15 | Bio-IT World | Appistry launches managed services for clinical sequencing, incorporating GenomePilot, and covering the entire pipeline from when data comes off the sequencers to results analysis.
Jul 14 | STAT | The impact factor is a poor measure of a journal's quality, and academics say it should either be overhauled or done away with entirely.
Jul 13 | Nature News & Comment | Wellcome Open Research is meant to allow Wellcome grant recipients to publish their findings more quickly. The charity hopes other funders will follow a similar model. Management of the venture will be contracted to F1000Research.
Jul 12 | Bio-IT World | News and product launches from around the Bio-IT landscape include a postdoctoral fellowship in genomics medicine in Alabama, a synthetic biology partnership, new Lustre storage, and the Broad's food allergy science institute.
Jul 12 | Forbes | Encouraging news is out today for the treatment of severe postpartum depression. Sage Therapeutics, a biotech company in Cambridge, Mass., reported that its experimental drug was able to relieve severe symptoms of postpartum depression for 70% of patients within a few days, and keep them in remission for a month.
Jul 11 | Bio-IT World | Intel may have missed out on a major government grant, but that hasn't stopped it from developing a collaborative cloud for genomicists and bioinformaticians that it wanted to build all along.
Jul 08 | Computerworld | Britain's vote to exit the European Union will depress global IT spending, according to Gartner analyst John-David Lovelock.
Jul 08 | Forbes | Three patients have died in a closely watched study of using genetically engineered white blood cells to treat adult leukemia patients, forcing the trial to be put on hold. The news is a blow for Juno Therapeutics, the biotechnology startup valued at $4.3 billion.
Jul 07 | Bio-IT World | Ranomics is capturing attention with its database of genomic variants. Counting BGI and Veritas among its new customers, the Toronto-based biotech startup plans to model and test every missense mutation to make genetic tests "more accurate and more conclusive than ever."
Jul 07 | Forbes | After a few weeks of hype around the Obama administration's efforts to speed cancer research, officials tonight announced plans to kickstart efforts around the president's Precision Medicine Initiative.
Jul 07 | Fortune | Johnson & Johnson turned off its last mainframe and plans to move 85% of its software to the cloud. Is it mainstream or an outlier?
Jul 06 | Xconomy | Bind Therapeutics and its treatment for treatment for non-small cell lung cancer may soon be owned by one-time partner Pfizer. Bind, which filed for Chapter 11 bankruptcy in May asked the court to approve a bid from Pfizer on July 1.
Jul 06 | Bio-IT World | Consumer genomics startup, Genos, is expanding its beta program and inviting Bio-IT World readers to sequence their whole exome at CLIA-certified 75x coverage for $399.
Jul 01 | Bio-IT World | Best Practices Amgen built a Real World Data platform to provide an enterprise-wide capability to better access and analyze available claims, electronic health records (EHRs), and cohort data, and address questions across the clinical and health IT development lifecycle.
Jun 29 | Bio-IT World PrecisionFDA announced the results of its Truth Challenge today. Entries from Verily Life Sciences, Kinghorn Center for Clinical Genomics, and Sanofi-Genzyme won top recognition. In addition to the winners, DNAnexus, Roche, Real Time Genomics, Sentieon, Qunitiles, Macrogen, the Broad Institute, and others participated.
Jun 29 | Bio-IT World The Cancer Moonshot Summit today served as a platform for many announcements from both the public and private sectors on ways to advance the Moonshot’s goals.